Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark S Anderson

Showing results (181-190 of 194) with videos related to

Pageof 20
Sort By:
Biorxiv : the Preprint Server for Biology|March 24, 2021
Longitudinal single-cell epitope and RNA-sequencing reveals the immunological impact of type 1 interferon autoantibodies in critical COVID-19: Anti-IFN antibodies in critical COVID-19 correlate with poor ISG response and upregulation of LAIR1 surface protein in PBMCsMonique G P van der Wijst, Sara E Vazquez, George C Hartoularos, et al.
Science Translational Medicine|August 25, 2021
Type I interferon autoantibodies are associated with systemic immune alterations in patients with COVID-19Monique G P van der Wijst, Sara E Vazquez, George C Hartoularos, et al.
Biorxiv : the Preprint Server for Biology|May 25, 2026
AEGIS reveals epitope- and clone-resolved convergence of CNS B and T cell autoreactivity in ROHHADAaron Bodansky, Vida Ahyong, Monica Dayao, et al.
Medrxiv : the Preprint Server for Health Sciences|January 22, 2026
Evidence for Maternal Autoantibodies in the Pathogenesis of Preterm BirthElze Rackaityte, Beltran Borges, Hannah M Kortbawi, et al.
The Journal of Experimental Medicine|April 23, 2021
Preexisting autoantibodies to type I IFNs underlie critical COVID-19 pneumonia in patients with APS-1Paul Bastard, Elizaveta Orlova, Leila Sozaeva, et al.
Medrxiv : the Preprint Server for Health Sciences|April 10, 2026
High risk of hypoxemic COVID-19 pneumonia in myasthenia gravis patients with type I IFN autoantibodiesAdrian Gervais, Astrid Marchal, Alexis Maillard, et al.
The New England Journal of Medicine|May 29, 2024
The Role of Interferon-γ in Autoimmune Polyendocrine Syndrome Type 1Vasileios Oikonomou, Grace Smith, Gregory M Constantine, et al.
Nature Biotechnology|August 29, 2020
Evaluation of SARS-CoV-2 serology assays reveals a range of test performanceJeffrey D Whitman, Joseph Hiatt, Cody T Mowery, et al.
Medrxiv : the Preprint Server for Health Sciences|June 9, 2020
Test performance evaluation of SARS-CoV-2 serological assaysJeffrey D Whitman, Joseph Hiatt, Cody T Mowery, et al.
The Journal of Experimental Medicine|October 1, 2024
Incontinentia pigmenti underlies thymic dysplasia, autoantibodies to type I IFNs, and viral diseasesJérémie Rosain, Tom Le Voyer, Xian Liu, et al.
Pageof 20

Showing results (181-190 of 194) with videos related to

Sort By:
Pageof 20
Biorxiv : the Preprint Server for Biology|March 24, 2021
Longitudinal single-cell epitope and RNA-sequencing reveals the immunological impact of type 1 interferon autoantibodies in critical COVID-19: Anti-IFN antibodies in critical COVID-19 correlate with poor ISG response and upregulation of LAIR1 surface protein in PBMCsMonique G P van der Wijst, Sara E Vazquez, George C Hartoularos, et al.
Science Translational Medicine|August 25, 2021
Type I interferon autoantibodies are associated with systemic immune alterations in patients with COVID-19Monique G P van der Wijst, Sara E Vazquez, George C Hartoularos, et al.
Biorxiv : the Preprint Server for Biology|May 25, 2026
AEGIS reveals epitope- and clone-resolved convergence of CNS B and T cell autoreactivity in ROHHADAaron Bodansky, Vida Ahyong, Monica Dayao, et al.
Medrxiv : the Preprint Server for Health Sciences|January 22, 2026
Evidence for Maternal Autoantibodies in the Pathogenesis of Preterm BirthElze Rackaityte, Beltran Borges, Hannah M Kortbawi, et al.
The Journal of Experimental Medicine|April 23, 2021
Preexisting autoantibodies to type I IFNs underlie critical COVID-19 pneumonia in patients with APS-1Paul Bastard, Elizaveta Orlova, Leila Sozaeva, et al.
Medrxiv : the Preprint Server for Health Sciences|April 10, 2026
High risk of hypoxemic COVID-19 pneumonia in myasthenia gravis patients with type I IFN autoantibodiesAdrian Gervais, Astrid Marchal, Alexis Maillard, et al.
The New England Journal of Medicine|May 29, 2024
The Role of Interferon-γ in Autoimmune Polyendocrine Syndrome Type 1Vasileios Oikonomou, Grace Smith, Gregory M Constantine, et al.
Nature Biotechnology|August 29, 2020
Evaluation of SARS-CoV-2 serology assays reveals a range of test performanceJeffrey D Whitman, Joseph Hiatt, Cody T Mowery, et al.
Medrxiv : the Preprint Server for Health Sciences|June 9, 2020
Test performance evaluation of SARS-CoV-2 serological assaysJeffrey D Whitman, Joseph Hiatt, Cody T Mowery, et al.
The Journal of Experimental Medicine|October 1, 2024
Incontinentia pigmenti underlies thymic dysplasia, autoantibodies to type I IFNs, and viral diseasesJérémie Rosain, Tom Le Voyer, Xian Liu, et al.
Pageof 20